Mesenchymal stem cells (MSCs) are multipotent cells that represent a promising source for
regenerative medicine. MSCs are capable of osteogenic, chondrogenic, adipogenic and …

Compared with traditional 2D adherent cell culture, 3D spheroidal cell aggregates, or
spheroids, are regarded as more physiological, and this technique has been exploited in the …

Bone-marrow-derived mesenchymal stem cells (MSCs) are of growing interest for the
treatment of diabetic wound healing. However, they are often associated with poor …

Human mesenchymal stem/stromal cells (hMSCs) present a key therapeutic cellular
intervention for use in cell and gene therapy (CGT) applications due to their …

Cell-matrix and cell-biomolecule interactions play critical roles in a diversity of biological
events including cell adhesion, growth, differentiation, and apoptosis. Evidence suggests …

Adult bone marrow multipotential stromal cells (MSCs) hold great promise in regenerative
medicine and tissue engineering. However, due to their low numbers upon harvesting …

Using endogenous mesenchymal stem cells for treating myocardial infarction and other
cardiovascular conditions typically results in poor efficacy, in part owing to the heterogeneity …

Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity globally,
representing approximately a third of all deaths every year. The greater part of these cases …

Bone marrow mesenchymal stem cells (BMSCs) are capable of differentiating into multiple
cell types, providing an alternative cell source for cell-based therapy and tissue engineering …

Short bowel syndrome (SBS), a condition defined by insufficient absorptive intestinal
epithelium, is a rare disease, with an estimated prevalence up to 0.4 in 10,000 people …